Yamaguchi Yuki, Shibata Hirotaka, Handa Hiroshi
Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan.
Biochim Biophys Acta. 2013 Jan;1829(1):98-104. doi: 10.1016/j.bbagrm.2012.11.007. Epub 2012 Nov 29.
DRB sensitivity-inducing factor (DSIF) and negative elongation factor (NELF) were originally identified as factors responsible for transcriptional inhibition by 5,6-dichloro-1-beta-d-ribofuranosyl-benzimidazole (DRB) and were later found to control transcription elongation, together with P-TEFb, at the promoter-proximal region. Although there is ample evidence that these factors play roles throughout the genome, other data also suggest gene- or tissue-specific roles for these factors. In this review, we discuss how these apparently conflicting data can be reconciled. In light of recent findings, we also discuss the detailed mechanism by which these factors control the elongation process at the molecular level. This article is part of a Special Issue entitled: RNA polymerase II Transcript Elongation.
DRB敏感性诱导因子(DSIF)和负性延伸因子(NELF)最初被鉴定为负责5,6-二氯-1-β-D-呋喃核糖基苯并咪唑(DRB)转录抑制的因子,后来发现它们与P-TEFb一起在启动子近端区域控制转录延伸。尽管有充分证据表明这些因子在整个基因组中发挥作用,但其他数据也表明这些因子具有基因或组织特异性作用。在本综述中,我们讨论了如何调和这些明显相互矛盾的数据。根据最近的研究结果,我们还讨论了这些因子在分子水平上控制延伸过程的详细机制。本文是名为:RNA聚合酶II转录延伸的特刊的一部分。